D-201-2013 Class III Terminated

Recalled by West-Ward Pharmaceutical Corp. — Eatontown, NJ

FDA drug recall D-201-2013 was initiated by West-Ward Pharmaceutical Corp. on Nov 30, 2012 and is designated Class III. Reason for recall: Labeling: Not elsewhere classified: On 12/12/11, DEA published a final rule in the Federal Register making this product a schedule IV (C-IV)controlled substance. This product is being recalled… The recall status is terminated (terminated Dec 18, 2014). Affected quantity: 1763 bottles.

Recall details

Product Type
Drugs
Report Date
Mar 27, 2013
Initiation Date
Nov 30, 2012
Termination Date
Dec 18, 2014
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
1763 bottles

Product description

Carisoprodol Tablets, USP, 350 mg Rx Only, 100 tablets per bottle, Rx Only, Manufactured by: West-ward Pharmaceutical Corp., Eatontown, NJ 07724, NDC 0143-1176-01.

Reason for recall

Labeling: Not elsewhere classified: On 12/12/11, DEA published a final rule in the Federal Register making this product a schedule IV (C-IV)controlled substance. This product is being recalled because this controlled product was not relabeled with the required "C-IV" imprint on the label for products distributed after the 06/11/12 deadline.

Distribution pattern

Nationwide

Code information

Lot #: 69160A

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-201-2013
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-201-2013. Report a data issue: hello@regdatalab.com.